WHAT ARE THE NEW FINDINGS? This large-scale systematic review and network meta-analysis of 270 randomised controlled trials demonstrates the optimal exercise prescription practices in the management ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

The search was performed by four blocks of keywords related to prevention, injury and diagnoses, sports, and randomised controlled trials. The searches were customised to accommodate the layout and ...

Background Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are the two most common forms of arthritis with a prevalence of 1% and 0.5% in Europe. Physical activity exerts a major influence on ...

Objectives This randomised sham-controlled clinical trial aims to compare the effects of acupuncture versus sham acupuncture on EMT in women with thin endometrium.

Methods: This randomized, sham-controlled trial was conducted at a single residential treatment center. Persons with OUD undergoing opioid discontinuation were assigned to active or sham device ...

Methods and analysis This trial is a randomised, double-blind, placebo-controlled study investigating the therapeutic potential of lyophilised faecal microbiota capsules (LFMCs) in individuals with ...

Randomized trial and human filters are not required in CENTRAL and should not be used. Cite this chapter as: Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Metzendorf M-I, ...

Randomized controlled trials articles from across Nature Portfolio Randomized controlled trials are clinical trials in which at least two interventions — the test treatment and a control ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in the STORM-PE clinical trial. The pivotal, prospective, multi-center randomized ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...